201 related articles for article (PubMed ID: 28510792)
21. Is laparoscopic resection adequate in patients with neuroendocrine pancreatic tumors?
Fernández-Cruz L; Blanco L; Cosa R; Rendón H
World J Surg; 2008 May; 32(5):904-17. PubMed ID: 18264824
[TBL] [Abstract][Full Text] [Related]
22. Insulinoma: a rare neuroendocrine pancreatic tumor.
Stamatakos M; Safioleas C; Tsaknaki S; Safioleas P; Iannescu R; Safioleas M
Chirurgia (Bucur); 2009; 104(6):669-73. PubMed ID: 20187464
[TBL] [Abstract][Full Text] [Related]
23. [Neuroendocrine tumors of the gastroenteropancreatic system. Diagnosis and surgical treatment].
Schürmann G; Brüwer M; Senninger N
Dtsch Med Wochenschr; 2000 Apr; 125(15):461-4. PubMed ID: 10800444
[No Abstract] [Full Text] [Related]
24. The Pancreatic Endocrine Tumors - Experience of First Surgical Clinic Iasi.
Târcoveanu E; Lupascu C; Vasilescu A; Moldovanu R; Andronic D; Ciobanu D; Bradea C
Chirurgia (Bucur); 2019; 114(5):639-649. PubMed ID: 31670640
[TBL] [Abstract][Full Text] [Related]
25. Surgical Management of Pancreatic Neuroendocrine Tumors.
Clancy TE
Hematol Oncol Clin North Am; 2016 Feb; 30(1):103-18. PubMed ID: 26614371
[TBL] [Abstract][Full Text] [Related]
26. Insulinoma-associated protein 1 (INSM1) is a robust marker for identifying and grading pancreatic neuroendocrine tumors.
Kim D; Viswanathan K; Goyal A; Rao R
Cancer Cytopathol; 2020 Apr; 128(4):269-277. PubMed ID: 31977134
[TBL] [Abstract][Full Text] [Related]
27. Neuroendocrine tumors of the pancreas.
Varshney S; Johnson CD
Indian J Gastroenterol; 2000; 19(4):181-3. PubMed ID: 11059186
[TBL] [Abstract][Full Text] [Related]
28. Endoscopic Ultrasound-Guided Radiofrequency Ablation: A New Therapeutic Approach for Pancreatic Neuroendocrine Tumors.
Oleinikov K; Dancour A; Epshtein J; Benson A; Mazeh H; Tal I; Matalon S; Benbassat CA; Livovsky DM; Goldin E; Gross DJ; Jacob H; Grozinsky-Glasberg S
J Clin Endocrinol Metab; 2019 Jul; 104(7):2637-2647. PubMed ID: 31102458
[TBL] [Abstract][Full Text] [Related]
29. Determinants of surgical resection for pancreatic neuroendocrine tumors.
Doi R
J Hepatobiliary Pancreat Sci; 2015 Aug; 22(8):610-7. PubMed ID: 25773163
[TBL] [Abstract][Full Text] [Related]
30. Synchronous Insulinoma and Glucagonoma: A Review of the Literature.
Damaskos C; Dimitroulis D; Garmpi A; Antoniou EA; Kouraklis G; Psilopatis I; Mavri M; Diamantis E; Marinos G; Kyriakos G; Farmaki P; Patsouras A; Kontzoglou K; Garmpis N
In Vivo; 2023; 37(6):2402-2408. PubMed ID: 37905620
[TBL] [Abstract][Full Text] [Related]
31. Topographic abnormalities of proinsulin to insulin conversion in functioning human insulinomas. Comparison of immunoelectron microscopic and clinical data.
Roth J; Komminoth P; Heitz PU
Am J Pathol; 1995 Aug; 147(2):489-502. PubMed ID: 7639339
[TBL] [Abstract][Full Text] [Related]
32. Intra-arterial calcium stimulation test for detection of insulinomas: detection rate, responses of pancreatic peptides, and its relationship to differentiation of tumor cells.
Won JG; Tseng HS; Yang AH; Tang KT; Jap TS; Kwok CF; Lee CH; Lin HD
Metabolism; 2003 Oct; 52(10):1320-9. PubMed ID: 14564685
[TBL] [Abstract][Full Text] [Related]
33. A malignant cause of hypoglycaemia: a metastatic insulin-secreting pancreatic neuroendocrine carcinoma.
Sandoval MA; Pagsisihan D; Berberabe A; Palugod-Lopez EG
BMJ Case Rep; 2016 Mar; 2016():. PubMed ID: 26994053
[TBL] [Abstract][Full Text] [Related]
34. A unique case of a nonfunctional metastatic pancreatic neuroendocrine tumor transforming into an insulin-secreting tumor with an unusual clinical course.
Vashi PG; Gupta D; Dahlk S
Pancreas; 2011 Jul; 40(5):781-4. PubMed ID: 21673539
[No Abstract] [Full Text] [Related]
35. Malignant-functioning neuroendocrine tumors of the pancreas: A survival analysis.
Keutgen XM; Nilubol N; Kebebew E
Surgery; 2016 May; 159(5):1382-9. PubMed ID: 26704781
[TBL] [Abstract][Full Text] [Related]
36. The Role of Surgery for Pancreatic Neuroendocrine Tumors.
Ziogas IA; Schmitz R; Moris D; Vatsaas CJ
Anticancer Res; 2022 Feb; 42(2):629-639. PubMed ID: 35093860
[TBL] [Abstract][Full Text] [Related]
37. ANTHROPOMETRIC FEATURES ARE NOT PREDICTIVE OF 72-HOUR FAST DURATION IN INSULINOMAS.
Donegan D; Jakubikova I; Vella A
Endocr Pract; 2017 Aug; 23(8):923-928. PubMed ID: 28614004
[TBL] [Abstract][Full Text] [Related]
38. Giant pancreatic tumor with clinical characteristics of insulinoma but without common pathologic features.
Oberheim NA; Kim A; Farkas RL; Ruan DT; Schoeniger LO; Schiffhauer LM; Moalem J
Endocr Pract; 2011; 17(2):e12-6. PubMed ID: 21324828
[TBL] [Abstract][Full Text] [Related]
39. Sustained pulsatile insulin secretion from adenomatous human beta-cells. Synchronous cycling of insulin, C-peptide, and proinsulin.
Chou HF; Ipp E; Bowsher RR; Berman N; Ezrin C; Griffiths S
Diabetes; 1991 Nov; 40(11):1453-8. PubMed ID: 1936605
[TBL] [Abstract][Full Text] [Related]
40. Pancreatic Neuroendocrine Tumors - Case Series and Literature Review.
Mihalache O; Doran H; Poiană C; Bîrligea A; Cîrstea MO; Pătraşcu T
Chirurgia (Bucur); 2019; 114(5):630-638. PubMed ID: 31670639
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
